RAYMOND DEBBANE - Director at LEXICON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
LXRX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by RAYMOND DEBBANE since 05 Jan 2025

Holdings reported by RAYMOND DEBBANE for LEXICON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 44,370,107 $22,628,754 $0.5100 13 May 2025 By Invus L.P., Invus Public Equities L.P., Invus US Partners LLC and related parties
Common Stock 1,385,689 $706,701 $0.5100 13 May 2025 Direct
Restricted Stock Units 89,312 $96,442 $2.62 03 Jun 2025 Direct Common Stock
Stock Option (Right to Buy) 103,806 03 Jun 2025 Direct Common Stock

Transactions reported by RAYMOND DEBBANE for LEXICON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.